New COVID-19 Vaccine to Seek Emergency Use Authorization from FDA
Sanofi and GSK are expected to request Emergency Use Authorization from the United States Food and Drug Administration (FDA) for its two-dose COVID-19 vaccine that uses traditional immunization technology rather than the new mRNA approach…